Indication

Mucormycosis

Mucormycosis is a rare, rapidly progressive, and life-threatening opportunistic fungal infection caused by molds within the order Mucorales, most frequently involving species such as *Rhizopus*, *Mucor*, and *Lichtheimia*. Read more about Mucormycosis

5 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Mucormycosis therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Mucormycosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mucormycosis.

Mucormycosis is a rare, rapidly progressive, and life-threatening opportunistic fungal infection caused by molds within the order Mucorales, most frequently involving species such as *Rhizopus*, *Mucor*, and *Lichtheimia*.

It predominantly targets vulnerable populations, including individuals with poorly controlled diabetes mellitus (particularly with ketoacidosis), hematologic malignancies, profound neutropenia, solid organ or stem cell transplants, or severe trauma.

The disease most commonly manifests in rhino-orbito-cerebral, pulmonary, cutaneous, or gastrointestinal forms, with the potential for widespread hematogenous dissemination.

Pathophysiologically, it is defined by marked angioinvasion, in which broad, ribbon-like, nonseptate or pauciseptate hyphae penetrate blood vessel walls, precipitating extensive thrombosis, tissue infarction, and rapidly destructive necrosis.

Personalize your experience

Follow Mucormycosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it